Correlation Between Grifols SA and AstraZeneca PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Grifols SA and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Grifols SA and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Grifols SA ADR and AstraZeneca PLC ADR, you can compare the effects of market volatilities on Grifols SA and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Grifols SA with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Grifols SA and AstraZeneca PLC.

Diversification Opportunities for Grifols SA and AstraZeneca PLC

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Grifols and AstraZeneca is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Grifols SA ADR and AstraZeneca PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC ADR and Grifols SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Grifols SA ADR are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC ADR has no effect on the direction of Grifols SA i.e., Grifols SA and AstraZeneca PLC go up and down completely randomly.

Pair Corralation between Grifols SA and AstraZeneca PLC

Given the investment horizon of 90 days Grifols SA ADR is expected to under-perform the AstraZeneca PLC. In addition to that, Grifols SA is 8.45 times more volatile than AstraZeneca PLC ADR. It trades about -0.13 of its total potential returns per unit of risk. AstraZeneca PLC ADR is currently generating about 0.17 per unit of volatility. If you would invest  6,535  in AstraZeneca PLC ADR on December 30, 2023 and sell it today you would earn a total of  240.00  from holding AstraZeneca PLC ADR or generate 3.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Grifols SA ADR  vs.  AstraZeneca PLC ADR

 Performance 
       Timeline  
Grifols SA ADR 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Grifols SA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in April 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
AstraZeneca PLC ADR 

Risk-Adjusted Performance

1 of 100

 
Low
 
High
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in AstraZeneca PLC ADR are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, AstraZeneca PLC is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Grifols SA and AstraZeneca PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Grifols SA and AstraZeneca PLC

The main advantage of trading using opposite Grifols SA and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Grifols SA position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.
The idea behind Grifols SA ADR and AstraZeneca PLC ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings